Ultragenyx Pharmaceutical Inc (RARE)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$26.44

Buy

$26.46

arrow-up$0.15 (+0.57%)

Prices updated at 12 May 2026, 16:30 EDT

Prices minimum 15 mins delay

Prices in USD

Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.

NASDAQ

-1.62%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$26.77 - $26.01
	$42.37 - $18.29
	-
	2,590.27m
	-
	-
	224,990
	-
	1,976,514.25
	1.29
	96.65m
	US90400D1081
	-6.10
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.